In this study, the SOD and GSH-Px activity in the livers and serums of T2DM mice treated with epimedin C in the EC30 group were significantly higher than those in the MC group (p < 0.05) but lower than those in the NC group. The gene discussed is SOD1; the disease is type 2 diabetes mellitus.